Enterococcal quorum-controlled protease alters phage infection

Emma K Sheriff1, Fernanda Salvato2, Shelby E Andersen1

  • 1Department of Immunology and Microbiology, University of Colorado Anschutz Medical Campus, Aurora, CO 80045.

Insights

Bacteriophages (phages) show promise against resistant bacteria. This study reveals how phage VPE25 impacts Enterococcus faecalis, identifying bacterial protein changes and a key virulence factor, GelE, that influences phage infection.

Area of Science:

  • Microbiology
  • Bacteriophage Therapy
  • Proteomics

Background:

  • Rising multidrug-resistant bacterial infections necessitate novel antimicrobials like bacteriophages (phages).
  • Understanding phage-host interactions is crucial for optimizing phage therapy effectiveness.
  • Enterococcus faecalis infections pose a significant public health challenge.

Approach:

  • Proteomic analysis was conducted on Enterococcus faecalis during infection with bacteriophage VPE25.
  • Bacterial protein abundance changes were quantified, with a focus on enterococcal gelatinase (GelE).
  • Plaque assays were performed on mutant strains (fsrA, gelE) to assess phage infection dynamics.

Key Points:

  • Numerous uncharacterized phage proteins were identified during E. faecalis infection.
  • Hundreds of bacterial protein abundance changes were observed, including a reduction in GelE.
  • GelE and its regulators (LrgA, LrgB) play a role in phage resistance, with mutations leading to increased plaque size.

Conclusions:

  • Phage VPE25 infection alters E. faecalis proteome, reducing virulence factors like GelE.
  • GelE-mediated protection against phage infection is linked to LrgA and LrgB.
  • Modulating GelE production could be a strategy to enhance phage therapy efficacy against E. faecalis.